Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EleVation Breast Biopsy System

K-Number: K211933 · 2021-07-15

Decision Date2021-07-15
Product CodeKNW
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

EleVation Breast Biopsy System is the device name listed in this FDA 510(k) record. The listed applicant is Bard Peripheral Vascular. It received FDA 510(k) clearance on 2021-07-15 under 510(k) number K211933. The device is classified under product code KNW. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EleVation Breast Biopsy System?

EleVation Breast Biopsy System is a medical device that received FDA 510(k) clearance on 2021-07-15. The listed applicant is Bard Peripheral Vascular. The 510(k) number is K211933.

When did EleVation Breast Biopsy System receive FDA 510(k) clearance?

EleVation Breast Biopsy System received FDA 510(k) clearance on 2021-07-15, under 510(k) number K211933.

Who is the listed applicant for EleVation Breast Biopsy System?

The FDA 510(k) record lists Bard Peripheral Vascular as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EleVation Breast Biopsy System?

The FDA product code for EleVation Breast Biopsy System is KNW.

Other records listing Bard Peripheral Vascular as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 26 devices →

Related Devices (Code: KNW)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.